AbbVie’s venetoclax misses Phase III endpoint in AML patients

AbbVie is developing venetoclax in alliance with Roche. Credit: AbbVie Inc.



  • AbbVie is developing venetoclax in alliance with Roche. Credit: AbbVie Inc.